InvestorsHub Logo
Followers 41
Posts 4235
Boards Moderated 0
Alias Born 08/01/2007

Re: leifsmith post# 107721

Saturday, 01/31/2015 7:33:55 AM

Saturday, January 31, 2015 7:33:55 AM

Post# of 146291
Exactly, leifsmith. There have been NO long-term safety studies on vaccines. I would love to see someone undertake an epidemiological study comparing cancer and autoimmune disease rates of heavily vaccinated people as compared to people who have had few vaccinations. It would be a horrendously difficult and time-consuming study, and there is certainly no profit in it for a drug company to subsidize such a study. It would be up to a university researcher/statistician to do something like that, and there would be no government grants available for something that goes against long-standing policy decisions.

Adjuvants and preservatives that are key parts of the mass manufacturing process -- who knows what cumulative exposure might do to someone long term.

It's great to prevent car accidents by getting drunk drivers off the roads. But there are still going to be car accidents, and having treatments for victims is necessary. There will always be that 193-car pileup that is caused by an unforeseen event like a blizzard. To say that we shouldn't develop treatments because people ought to be able to avoid injury would be crazy. Likewise, saying that vaccines will prevent all disease is illogical.

But really, this is not the vaccine board. The merits or deficits of vaccines are not the subject here, except insofar as they affect funding for research on treatments. I understand that people are bored as we await results from what I think will be a binary event for NNVC -- will there be good results, or bad, from the upcoming tests? Upcoming data is going to be incredibly crucial for the company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News